Skip to contentBaker Brothers Life Sciences LP — GENOMIC HEALTH INC insider: 549 transactions · InsiderLensBaker Brothers Life Sciences LP
- Director at SYNTA PHARMACEUTICALS CORP · on record since Jun 20, 2023
- Former 10% Owner at Neurogene Inc. · on record since Dec 20, 2023
- Former 10% Owner at SEATTLE GENETICS INC /WA · on record since Dec 18, 2023
- Director at vTv Therapeutics Inc. · on record since Mar 7, 2024
- Director at Immunocore Holdings plc · on record since May 29, 2024
- Director at BICYCLE THERAPEUTICS PLC · on record since May 29, 2024
- 10% owner at BICYCLE THERAPEUTICS PLC · on record since May 29, 2024
- Director at Kymera Therapeutics, Inc. · on record since Apr 1, 2024
- Director at TScan Therapeutics, Inc. · on record since May 22, 2026
- Former 10% owner and director at IGM Biosciences, Inc. · on record since Aug 18, 2025
- 10% owner at Kymera Therapeutics, Inc. · on record since Dec 11, 2025
- Director at INCYTE CORP · on record since Apr 2, 2026
- 10% owner at INCYTE CORP · on record since Apr 2, 2026
- Director at Replimune Group, Inc. · on record since Apr 7, 2026
- 10% owner at Replimune Group, Inc. · on record since Apr 7, 2026
- Director at BeOne Medicines Ltd. · on record since May 27, 2026
- Director at Prelude Therapeutics Inc · on record since Apr 22, 2026
- 10% owner at Prelude Therapeutics Inc · on record since Apr 22, 2026
- Director at GENOMIC HEALTH INC · on record since Jul 31, 2012
- Director at XOMA LTD /DE/ · on record since Jul 23, 2012
- Director at TRIMERIS INC · on record since Jul 13, 2012
- 10% owner at TRIMERIS INC · on record since Jul 13, 2012
- 10% owner at XOMA LTD /DE/ · on record since Oct 31, 2012
- 10% owner at GENOMIC HEALTH INC · on record since Nov 23, 2012
- Director at ACADIA PHARMACEUTICALS INC · on record since Jan 23, 2013
- 10% owner at ACADIA PHARMACEUTICALS INC · on record since Jan 23, 2013
- Director at SEATTLE GENETICS INC /WA · on record since May 21, 2013
- 10% owner at SEATTLE GENETICS INC /WA · on record since May 21, 2013
- 10% owner at BIOCRYST PHARMACEUTICALS INC · on record since Aug 2, 2013
- Director at IDERA PHARMACEUTICALS, INC. · on record since Mar 19, 2014
- Director at Kiniksa Pharmaceuticals International, plc · on record since Jun 2, 2026
- Director at Denali Therapeutics Inc. · on record since Jun 5, 2026
- 10% owner at Mirati Therapeutics, Inc. · on record since Feb 2, 2015
- Director at ALEXION PHARMACEUTICALS INC · on record since Jun 30, 2015
- Former 10% owner and Director at TRIMERIS INC · on record since Jun 23, 2015
- Former 10% owner at XOMA LTD /DE/ · on record since Jul 23, 2015
- 10% owner at Neurogene Inc. · on record since Aug 10, 2015
- 10% owner at BeOne Medicines Ltd. · on record since Feb 9, 2016
- Director at Neurogene Inc. · on record since May 9, 2017
- 10% owner at IDERA PHARMACEUTICALS, INC. · on record since Mar 15, 2018
- 10% owner at Kiniksa Pharmaceuticals International, plc · on record since May 31, 2018
- Director at Kodiak Sciences Inc. · on record since Oct 11, 2018
- 10% owner at Kodiak Sciences Inc. · on record since Oct 11, 2018
- Director at IGM Biosciences, Inc. · on record since Sep 20, 2019
- 10% owner at IGM Biosciences, Inc. · on record since Sep 20, 2019
- Director at SMI PRODUCTS INC · on record since Dec 20, 2019
- 10% owner at SMI PRODUCTS INC · on record since Oct 15, 2019
- Director at Zymeworks Inc. · on record since Mar 16, 2020
- Director at Spyre Therapeutics, Inc. · on record since Feb 25, 2021
- Director at Talis Biomedical Corp · on record since Feb 19, 2021
- 10% owner at Talis Biomedical Corp · on record since Feb 19, 2021
- Director at DBV Technologies S.A. · on record since Jan 11, 2021
- 10% owner at DBV Technologies S.A. · on record since Jan 11, 2021
- 10% owner at TScan Therapeutics, Inc. · on record since Jul 15, 2021
Insider trading activity of Baker Brothers Life Sciences LP
- Transactions on record
- 549
- since Nov 14, 2012
- Open-market buys
- 241
- $1.1B
- Open-market sells
- 133
- $793.8M
- Companies traded
- 16
- last filing Dec 19, 2025
Figures computed from official regulatory filings — methodology.
Companies where Baker Brothers Life Sciences LP has traded
- Kodiak Sciences Inc.75 tx · $315.6M · Dec 19, 2025
- INCYTE CORP85 tx · $103.5B · Jul 2, 2025
- Prelude Therapeutics Inc4 tx · $25M · Jun 13, 2025
- BeOne Medicines Ltd.14 tx · $649.1M · May 22, 2025
- DBV Technologies S.A.4 tx · Mar 31, 2025
- IGM Biosciences, Inc.21 tx · $3.4M · Jan 3, 2025
- Kiniksa Pharmaceuticals International, plc28 tx · $84M · Oct 8, 2024
- SYNTA PHARMACEUTICALS CORP32 tx · $11.9M · Nov 21, 2023
- SMI PRODUCTS INC14 tx · $1.5M · Aug 17, 2023
Track record of Baker Brothers Life Sciences LP
Statistical track record
Free- Open-market buys
- 261
- Last buy
- Dec 18, 2025
Win rates and median returns are available with a free account (5 insiders/month).
Create a free account→Transaction history of Baker Brothers Life Sciences LP
Co-insiders of Baker Brothers Life Sciences LP
This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →
1 tx · Jun 13, 2022
14159 capital (GP), LLCIDERA PHARMACEUTICALS, INC. +4
| Company | Filed | Type | Qty | Price | Value · USD | Src |
|---|
| Dec 19, 2025 | Buy | 2,391,268 | 23.00 USD | $55M | SEC |
| Dec 19, 2025 | Buy | 217,428 | 23.00 USD | $5M | SEC |
| Jul 2, 2025 | Award | 492 | 0.00 USD | $0 | SEC |
| Jul 2, 2025 | Award | 492 | 0.00 USD | $0 | SEC |
| Jun 13, 2025 | AwardD | 76,000 | 0.00 USD | $0 | SEC |
| Jun 13, 2025 | AwardD | 76,000 | 0.00 USD | $0 | SEC |
| Jun 12, 2025 | AwardD | 9,216 | 0.00 USD | $0 | SEC |
| Jun 12, 2025 | Award | 2,518 | 0.00 USD | $0 | SEC |
| Jun 12, 2025 | AwardD | 9,216 | 0.00 USD | $0 | SEC |
| Jun 12, 2025 | Award | 2,518 | 0.00 USD | $0 | SEC |
| May 22, 2025 | AwardD | 45,500 | 0.00 USD | $0 | SEC |
| May 22, 2025 | Award | 21,970 | 0.00 USD | $0 | SEC |
| May 22, 2025 | Award | 21,970 | 0.00 USD | $0 | SEC |
| May 22, 2025 | AwardD | 45,500 | 0.00 USD | $0 | SEC |
| Mar 31, 2025 | AwardD | 2,299,656 | — | — | SEC |
| Mar 31, 2025 | AwardD | 2,299,656 | — | — | SEC |
| Mar 31, 2025 | AwardD | 25,005,240 | — | — | SEC |
| Mar 31, 2025 | AwardD | 25,005,240 | — | — | SEC |
| Jan 3, 2025 | Award | 1,994 | 0.00 USD | $0 | SEC |
| Jan 3, 2025 | Award | 1,994 | 0.00 USD | $0 | SEC |
| Dec 10, 2024 | Sell | -83,036 | 186.50 USD | $15.5M | SEC |
| Dec 10, 2024 | Sell | -3,074 | 208.01 USD | $639.4K | SEC |
| Dec 10, 2024 | Sell | -916,964 | 186.50 USD | $171M | SEC |
| Dec 10, 2024 | Sell | -33,943 | 208.01 USD | $7.1M | SEC |
| Oct 8, 2024 | AwardD | 28,384 | 0.00 USD | $0 | SEC |